vemurafenib,cobimetinib,atezolizumab
roche,exelixis
['9515', 'triplet']
 continues: triplet therapy (io and tt) showed an encouraging high response rate in patients that required steroids and/or had neurologic symptoms. [abstract 9515] #asco22
The Melanoma Research Foundation (MRF) is the largest independent organization devoted to #melanoma. Help us find pathways to a cure! #GetNaked